Delivery Order SPE2DB22D1106-SPE2DB25FDQM2

Award Date 12/13/24
Potential Completion Date 12/16/24
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDQM2
    Delivery Order

This federal contract award is a $3,281.28 delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the provision of 250 mcg/0.5 mL syringes of the drug Ovidrel, with a period of performance running through December 16, 2024. This order is placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and spanning through November 2026. The IDC serves as a primary vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not include any set-aside designation, indicating open competition. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov) and has a proven track record of providing essential medical commodities to federal agencies, including the DLA and the Department of Justice Federal Bureau of Investigation.

Generated 3/14/25, 9:43 AM